Stem Cell Transplant in Immune-deficiency-associated Vaccine-derived Poliovirus.

IRIS RAG SCID VAPP acute flaccid paralysis disseminated BCG iVDPV immunodeficiency intravenous immune globulin pocapavir polio poliomyelitis stem cell transplant transplant vaccine-associated vaccine-derived poliovirus

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 21 11 2023
accepted: 15 01 2024
medline: 8 2 2024
pubmed: 8 2 2024
entrez: 8 2 2024
Statut: epublish

Résumé

Patients with severe primary immunodeficiency are at risk for complications from live-attenuated vaccines. Here, we report a case of a vaccine-associated paralytic polio and Bacille Calmette-Guérin disease in a 6-month-old girl with severe combined immunodeficiency resulting from homozygous recombinant activating gene 1 deficiency. The patient was successfully treated with intravenous immunoglobulins and oral pocapavir for poliovirus, and antimycobacterial therapy for regional Bacille Calmette-Guérin disease, allowing stem cell transplant. Following transplantation, poliovirus type 3 with 13 mutations was detected from cerebrospinal fluid but not from stool, indicating ongoing viral evolution in the central nervous system despite pocapavir treatment. Clinical improvement and immune reconstitution allowed the patient to be successfully discharged with no further detection of poliovirus.

Identifiants

pubmed: 38328499
doi: 10.1093/ofid/ofad678
pii: ofad678
pmc: PMC10849832
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofad678

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts.

Auteurs

Heena Ranchod (H)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Wayne Howard (W)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Adele Roux (A)

Dr Adéle Roux Practice, Life Groenkloof Hospital, Pretoria, South Africa.

Walda van Zyl (W)

Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, National Health Laboratory Services-Tshwane Academic Division, Pretoria, South Africa.

Pieter Ekermans (P)

Department of Medical Microbiology, Ampath Laboratories, Pretoria, South Africa.

Sylvia van den Berg (S)

Department of Immunology, Ampath Laboratories, Pretoria, South Africa.

Lerato Seakamela (L)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

Koketso Makua (K)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

Mukhlid Yousif (M)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Rosinah Sibiya (R)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

Heleen Du Plessis (H)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

Emmanuel Phalane (E)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Department of Virology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Kerrigan McCarthy (K)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

Shelina Moonsamy (S)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.

David Reynders (D)

Department of Paediatrics, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Jeffrey Hincks (J)

ViroDefense, Chevy Chase, Maryland, USA.

Melinda S Suchard (MS)

Centre for Vaccines and Immunology, National Institute for Communicable Diseases, Johannesburg, South Africa.
Department of Chemical Pathology, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Nicolette M du Plessis (NM)

Department of Paediatrics, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.

Classifications MeSH